Ubie, founded in 2017, has announced it has now secured over $125 million in cumulative funding, as it accelerates its expansion into the U.S. with generative AI and provider-focused solutions. The milestone builds upon the company’s previous $26.2M Series C, bringing total backing to more than $59.8M since the previous raise in August 2022.
Led by CEO and Co-founder Kota Kubo, Ubie has seen its U.S. Symptom Checker platform grow organically by 85%, reaching more than 4 million U.S. users. Globally, the Checker now engages over 13 million people each month. Ubie’s expansion in the U.S. is further validated through strategic investments from major partners including Google, JAPAN POST CAPITAL, NTT DOCOMO, SEVEN‑ELEVEN JAPAN, Japan Finance Corporation, and The Shoko Chukin Bank.
With recent acceptance into the Mayo Clinic Platform Accelerate program, Ubie plans to refine its provider tools using de-identified records from 3 million patients. The firm also intends to add generative AI functionality to its Symptom Checker, offering richer patient education and disease insights earlier in the care journey.
Editorial Insight: Why Ubie’s U.S. Strategy Could Reshape Digital Healthcare
In an era marked by telehealth expansion and AI integration, Ubie’s dual-pronged focus on patient-facing symptom tools and provider-grade AI solutions positions it well across the healthcare spectrum. By enriching patient education with generative AI, the company is bringing medical literacy into patients’ homes—potentially reducing strain on clinical resources and enabling more informed care-seeking.
On the provider side, collaboration with the Mayo Clinic signifies a shift from consumer tools to clinical-grade platforms. This move not only enhances diagnostic trust but could streamline workflows and reduce administrative drag for clinicians. With over 1,800 Japanese institutions already using Ubie’s Medical Navigator, its expansion into generative AI-backed intake processes underscores a scalable model adaptable across global healthcare systems.
Supported by established partners, a seasoned founding team led by Kota Kubo, and strong user growth metrics, Ubie is shaping up to be a compelling force in AI-driven healthcare tools. Their balanced focus on both patient interaction and provider needs illustrates a mature strategy that could well define the next frontier in digital health.
If you need further assistance or have any corrections, please reach out to editor@thetimesmag.com.
